Trade Tactile Systems - TCMD CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Tactile Systems Technology Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 13.97 |
Open* | 14.08 |
1-Year Change* | 69.84% |
Day's Range* | 13.91 - 14.49 |
52 wk Range | 8.18-26.11 |
Average Volume (10 days) | 643.20K |
Average Volume (3 months) | 9.58M |
Market Cap | 297.24M |
P/E Ratio | 11.81 |
Shares Outstanding | 23.50M |
Revenue | 270.67M |
EPS | 1.07 |
Dividend (Yield %) | N/A |
Beta | 1.34 |
Next Earnings Date | Feb 19, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 29, 2023 | 13.99 | -0.06 | -0.43% | 14.05 | 14.51 | 13.91 |
Nov 28, 2023 | 13.97 | -0.10 | -0.71% | 14.07 | 14.22 | 13.50 |
Nov 27, 2023 | 14.00 | 0.18 | 1.30% | 13.82 | 14.30 | 13.77 |
Nov 24, 2023 | 13.76 | 0.26 | 1.93% | 13.50 | 14.27 | 13.47 |
Nov 22, 2023 | 13.43 | 0.70 | 5.50% | 12.73 | 13.57 | 12.68 |
Nov 21, 2023 | 12.62 | -0.10 | -0.79% | 12.72 | 12.85 | 12.18 |
Nov 20, 2023 | 12.61 | 1.21 | 10.61% | 11.40 | 12.67 | 11.36 |
Nov 17, 2023 | 11.47 | 0.14 | 1.24% | 11.33 | 11.73 | 11.33 |
Nov 16, 2023 | 11.34 | 0.11 | 0.98% | 11.23 | 11.37 | 10.88 |
Nov 15, 2023 | 11.31 | 0.47 | 4.34% | 10.84 | 11.55 | 10.84 |
Nov 14, 2023 | 10.99 | 0.23 | 2.14% | 10.76 | 11.26 | 10.59 |
Nov 13, 2023 | 10.71 | -0.01 | -0.09% | 10.72 | 11.03 | 10.43 |
Nov 10, 2023 | 10.67 | 0.06 | 0.57% | 10.61 | 10.77 | 10.34 |
Nov 9, 2023 | 10.63 | 0.57 | 5.67% | 10.06 | 10.97 | 10.01 |
Nov 8, 2023 | 9.96 | -0.01 | -0.10% | 9.97 | 10.46 | 9.78 |
Nov 7, 2023 | 9.90 | -0.75 | -7.04% | 10.65 | 10.80 | 9.66 |
Nov 6, 2023 | 12.61 | -0.71 | -5.33% | 13.32 | 13.32 | 12.44 |
Nov 3, 2023 | 12.85 | 0.17 | 1.34% | 12.68 | 13.10 | 12.51 |
Nov 2, 2023 | 12.36 | 0.58 | 4.92% | 11.78 | 12.45 | 11.70 |
Nov 1, 2023 | 11.68 | 0.98 | 9.16% | 10.70 | 11.79 | 10.70 |
Tactile Systems Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 19, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 Tactile Systems Technology Inc Earnings Release Q4 2023 Tactile Systems Technology Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 246.785 | 208.057 | 187.13 | 189.492 | 143.751 |
Revenue | 246.785 | 208.057 | 187.13 | 189.492 | 143.751 |
Cost of Revenue, Total | 126.658 | 111.289 | 97.528 | 90.108 | 75.101 |
Gross Profit | 120.127 | 96.768 | 89.602 | 99.384 | 68.65 |
Total Operating Expense | 259.543 | 209.819 | 189.558 | 178.994 | 140.761 |
Selling/General/Admin. Expenses, Total | 111.365 | 92.132 | 84.366 | 83.712 | 60.371 |
Research & Development | 7.088 | 5.659 | 5.264 | 5.174 | 5.289 |
Operating Income | -12.758 | -1.762 | -2.428 | 10.498 | 2.99 |
Other, Net | -2.715 | -0.531 | 0.167 | 0.631 | 0.486 |
Net Income Before Taxes | -15.473 | -2.293 | -2.261 | 11.129 | 3.476 |
Net Income After Taxes | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Net Income Before Extra. Items | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Net Income | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Total Adjustments to Net Income | 0 | ||||
Income Available to Common Excl. Extra. Items | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Income Available to Common Incl. Extra. Items | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Dilution Adjustment | |||||
Diluted Net Income | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Diluted Weighted Average Shares | 20.068 | 19.7195 | 19.3469 | 19.6411 | 19.3476 |
Diluted EPS Excluding Extraordinary Items | -0.89027 | -0.59895 | -0.03205 | 0.55857 | 0.34232 |
Diluted Normalized EPS | -0.89027 | -0.59895 | 0.04859 | 0.55857 | 0.34232 |
Total Extraordinary Items | |||||
Unusual Expense (Income) | 2.4 | ||||
Depreciation / Amortization | 14.432 | 0.739 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 68.339 | 58.846 | 73.9 | 65.262 | 59.645 |
Revenue | 68.339 | 58.846 | 73.9 | 65.262 | 59.645 |
Cost of Revenue, Total | 34.198 | 31.693 | 34.156 | 33.387 | 29.798 |
Gross Profit | 34.141 | 27.153 | 39.744 | 31.875 | 29.847 |
Total Operating Expense | 66.281 | 62.652 | 66.05 | 66.882 | 63.732 |
Selling/General/Admin. Expenses, Total | 29.039 | 27.421 | 28.157 | 27.921 | 30.34 |
Research & Development | 1.833 | 2.233 | 2.139 | 1.581 | 1.849 |
Operating Income | 2.058 | -3.806 | 7.85 | -1.62 | -4.087 |
Other, Net | -0.838 | -0.993 | -0.95 | -0.736 | -0.573 |
Net Income Before Taxes | 1.22 | -4.799 | 6.9 | -2.356 | -4.66 |
Net Income After Taxes | -0.1 | -1.886 | 4.621 | -2.279 | -4.64 |
Net Income Before Extra. Items | -0.1 | -1.886 | 4.621 | -2.279 | -4.64 |
Net Income | -0.1 | -1.886 | 4.621 | -2.279 | -4.64 |
Income Available to Common Excl. Extra. Items | -0.1 | -1.886 | 4.621 | -2.279 | -4.64 |
Income Available to Common Incl. Extra. Items | -0.1 | -1.886 | 4.621 | -2.279 | -4.64 |
Diluted Net Income | -0.1 | -1.886 | 4.621 | -2.279 | -4.64 |
Diluted Weighted Average Shares | 23.3525 | 21.2838 | 20.206 | 20.1399 | 20.0248 |
Diluted EPS Excluding Extraordinary Items | -0.00428 | -0.08861 | 0.22869 | -0.11316 | -0.23171 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.00428 | -0.08861 | 0.22869 | -0.11316 | -0.23171 |
Depreciation / Amortization | 1.211 | 1.305 | 1.598 | 3.993 | 1.745 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 119.763 | 113.547 | 123.613 | 108.335 | 84.961 |
Cash and Short Term Investments | 38.059 | 40.711 | 58.563 | 53.381 | 45.885 |
Cash & Equivalents | 21.929 | 28.229 | 47.855 | 22.77 | 20.099 |
Short Term Investments | 16.13 | 12.482 | 10.708 | 30.611 | 25.786 |
Total Receivables, Net | 54.826 | 49.478 | 43.849 | 33.444 | 26.125 |
Accounts Receivable - Trade, Net | 54.826 | 49.478 | 43.849 | 33.444 | 24.332 |
Total Inventory | 23.124 | 19.217 | 18.563 | 19.059 | 11.189 |
Prepaid Expenses | 3.754 | 4.141 | 2.638 | 2.451 | 1.762 |
Other Current Assets, Total | |||||
Total Assets | 254.996 | 244.27 | 174.087 | 151.752 | 107.071 |
Property/Plant/Equipment, Total - Net | 27.399 | 30.734 | 27.089 | 23.293 | 4.81 |
Property/Plant/Equipment, Total - Gross | 38.184 | 39.777 | 34.465 | 28.604 | 10.45 |
Accumulated Depreciation, Total | -10.785 | -9.043 | -7.376 | -5.311 | -5.64 |
Intangibles, Net | 50.375 | 54.081 | 1.68 | 5.312 | 5.339 |
Note Receivable - Long Term | 23.061 | 12.847 | 9.433 | 4.184 | 1.884 |
Other Long Term Assets, Total | 3.335 | 1.998 | 12.272 | 10.628 | 10.077 |
Total Current Liabilities | 64.33 | 34.461 | 26.714 | 21.428 | 16.076 |
Accounts Payable | 9.984 | 5.023 | 4.197 | 3.843 | 5.11 |
Accrued Expenses | 28.84 | 19.907 | 18.017 | 16.05 | 10.201 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 22.538 | 6.571 | 4.5 | 1.535 | 0.765 |
Total Liabilities | 133.596 | 116.043 | 49.337 | 39.157 | 17.801 |
Total Long Term Debt | 45.895 | 51.79 | 0 | 0 | 0 |
Other Liabilities, Total | 23.371 | 29.76 | 22.623 | 17.729 | 1.725 |
Total Equity | 121.4 | 128.227 | 124.75 | 112.595 | 89.27 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Common Stock | 0.02 | 0.02 | 0.019 | 0.019 | 0.019 |
Additional Paid-In Capital | 131.001 | 119.962 | 104.675 | 91.874 | 79.554 |
Retained Earnings (Accumulated Deficit) | -9.621 | 8.245 | 20.056 | 20.676 | 9.705 |
Other Equity, Total | 0.026 | -0.008 | |||
Total Liabilities & Shareholders’ Equity | 254.996 | 244.27 | 174.087 | 151.752 | 107.071 |
Total Common Shares Outstanding | 20.2527 | 19.8778 | 19.4927 | 19.1527 | 18.6311 |
Treasury Stock - Common | 0 | ||||
Goodwill, Net | 31.063 | 31.063 | |||
Current Port. of LT Debt/Capital Leases | 2.968 | 2.96 | |||
Long Term Debt | 45.895 | 51.79 | |||
Deferred Income Tax | 0 | 0.032 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 151.69 | 149.558 | 145.433 | 119.763 | 116.796 |
Cash and Short Term Investments | 79.639 | 76.431 | 68.792 | 38.059 | 38.478 |
Cash & Equivalents | 66.036 | 63.212 | 55.011 | 21.929 | 23.426 |
Short Term Investments | 13.603 | 13.219 | 13.781 | 16.13 | 15.052 |
Total Receivables, Net | 43.879 | 48.332 | 51.751 | 54.826 | 51.814 |
Accounts Receivable - Trade, Net | 43.879 | 46.553 | 51.02 | 54.826 | 51.814 |
Total Inventory | 23.498 | 20.315 | 20.014 | 23.124 | 23.02 |
Prepaid Expenses | 4.674 | 4.48 | 4.876 | 3.754 | 3.484 |
Total Assets | 293.307 | 273.728 | 275.501 | 254.996 | 248.526 |
Property/Plant/Equipment, Total - Net | 24.789 | 25.812 | 26.288 | 27.399 | 28.652 |
Intangibles, Net | 47.628 | 48.559 | 49.465 | 50.375 | 51.308 |
Note Receivable - Long Term | 14.636 | 15.43 | 19.983 | 23.061 | 17.703 |
Other Long Term Assets, Total | 23.501 | 3.306 | 3.269 | 3.335 | 3.004 |
Total Current Liabilities | 45.618 | 48.52 | 51.404 | 64.33 | 55.661 |
Accounts Payable | 6.402 | 9.296 | 9.59 | 9.984 | 11.171 |
Accrued Expenses | 22.707 | 21.495 | 20.574 | 28.84 | 23.014 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 13.553 | 14.761 | 18.272 | 22.538 | 18.508 |
Total Liabilities | 110.477 | 114.965 | 119.339 | 133.596 | 134.129 |
Total Long Term Debt | 43.592 | 44.436 | 45.166 | 45.895 | 46.625 |
Other Liabilities, Total | 21.267 | 22.009 | 22.769 | 23.371 | 31.794 |
Total Equity | 182.83 | 158.763 | 156.162 | 121.4 | 114.397 |
Common Stock | 0.023 | 0.023 | 0.023 | 0.02 | 0.02 |
Additional Paid-In Capital | 172.115 | 170.347 | 167.646 | 131.001 | 128.619 |
Retained Earnings (Accumulated Deficit) | 10.692 | -11.607 | -11.507 | -9.621 | -14.242 |
Total Liabilities & Shareholders’ Equity | 293.307 | 273.728 | 275.501 | 254.996 | 248.526 |
Total Common Shares Outstanding | 23.4976 | 23.4583 | 23.2351 | 20.2527 | 20.1557 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Goodwill, Net | 31.063 | 31.063 | 31.063 | 31.063 | 31.063 |
Current Port. of LT Debt/Capital Leases | 2.956 | 2.968 | 2.968 | 2.968 | 2.968 |
Long Term Debt | 43.592 | 44.436 | 45.166 | 45.895 | 46.625 |
Deferred Income Tax | 0 | 0.049 | |||
Other Equity, Total | 0 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.866 | -11.811 | -0.62 | 10.971 | 6.623 |
Cash From Operating Activities | 5.209 | 2.631 | 2.794 | 2.51 | 9.007 |
Cash From Operating Activities | 6.268 | 3.681 | 2.794 | 3.538 | 3.635 |
Deferred Taxes | -0.032 | 10.23 | -1.233 | -0.146 | -6.182 |
Non-Cash Items | 21.47 | 9.993 | 14.612 | 10.672 | 10.512 |
Cash Taxes Paid | 0.044 | 1.593 | 0.543 | 0.344 | 2.883 |
Cash Interest Paid | 2.186 | 0.13 | 0 | 0 | 0.009 |
Changes in Working Capital | -4.631 | -9.462 | -12.759 | -22.525 | -5.581 |
Cash From Investing Activities | -1.909 | -82.184 | 20.179 | -2.335 | -14.726 |
Capital Expenditures | -1.92 | -2.355 | -2.291 | -5.988 | -9.546 |
Other Investing Cash Flow Items, Total | 0.011 | -79.829 | 22.47 | 3.653 | -5.18 |
Cash From Financing Activities | -9.6 | 59.927 | 2.112 | 2.496 | 1.85 |
Financing Cash Flow Items | -5.039 | -1.361 | -1.854 | -3.391 | -2.379 |
Total Cash Dividends Paid | |||||
Issuance (Retirement) of Stock, Net | 1.439 | 6.288 | 3.966 | 5.887 | 4.229 |
Issuance (Retirement) of Debt, Net | -6 | 55 | |||
Net Change in Cash | -6.3 | -19.626 | 25.085 | 2.671 | -3.869 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -1.886 | -17.866 | -22.487 | -20.208 | -15.568 |
Cash From Operating Activities | -0.502 | 5.209 | 1.354 | -0.9 | -3.206 |
Cash From Operating Activities | 1.629 | 6.268 | 4.67 | 3.015 | 1.507 |
Deferred Taxes | 0 | -0.032 | 0.017 | 0.094 | 0.115 |
Non-Cash Items | 2.686 | 21.47 | 18.599 | 12.671 | 8.678 |
Cash Taxes Paid | 0.006 | 0.044 | 0.029 | 0.028 | 0.012 |
Changes in Working Capital | -2.931 | -4.631 | 0.555 | 3.528 | 2.062 |
Cash From Investing Activities | -0.291 | -1.909 | -1.844 | -0.416 | -0.175 |
Capital Expenditures | -0.291 | -1.92 | -1.844 | -0.416 | -0.175 |
Other Investing Cash Flow Items, Total | 0.011 | ||||
Cash From Financing Activities | 33.875 | -9.6 | -4.313 | -3.563 | -3.698 |
Financing Cash Flow Items | 0 | -5.039 | -0.039 | -0.039 | -0.039 |
Issuance (Retirement) of Stock, Net | 34.625 | 1.439 | 0.976 | 0.976 | 0.091 |
Net Change in Cash | 33.082 | -6.3 | -4.803 | -4.879 | -7.079 |
Issuance (Retirement) of Debt, Net | -0.75 | -6 | -5.25 | -4.5 | -3.75 |
Cash Interest Paid | 0.927 | 2.186 | 1.433 | 0.448 | 0.413 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Tactile Systems Company profile
About Tactile Systems Technology Inc
Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Tactile Systems Technology Inc revenues increased 11% to $208.1M. Net loss increased from $620K to $11.8M. Revenues reflect Flexitouch system segment increase of 8% to $176.2M, Entre/Actitouch systems segment increase of 15% to $26.7M. Higher net loss reflects Sales and marketing - Balancing value increase of 11% to $82.7M (expense), Stock-based Compensation in SGA increase of 13% to $5.4M (expense).
Industry: | Medical Equipment |
1331 Tyler St NE Ste 200
MINNEAPOLIS
MINNESOTA 55413-1638
US
Income Statement
- Annual
- Quarterly
News

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023
Gold Rises as Traders price-in Fed Rate Cuts
Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.
13:17, 20 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com